SATB2 is a novel biomarker and therapeutic target for cancer

MLA

Sanjit K Roy, et al. “SATB2 Is a Novel Biomarker and Therapeutic Target for Cancer.” Journal of Cellular and Molecular Medicine, vol. 24, Sept. 2020, pp. 11064–69. EBSCOhost, https://doi.org/10.1111/jcmm.15755.

APA

Sanjit K Roy, Rakesh K. Srivastava, Sudesh Srivastav, Sharmila Shankar, & Anju Shrivastava. (2020). SATB2 is a novel biomarker and therapeutic target for cancer. Journal of Cellular and Molecular Medicine, 24, 11064–11069. https://doi.org/10.1111/jcmm.15755

Chicago

Sanjit K Roy, Rakesh K. Srivastava, Sudesh Srivastav, Sharmila Shankar, and Anju Shrivastava. 2020. “SATB2 Is a Novel Biomarker and Therapeutic Target for Cancer.” Journal of Cellular and Molecular Medicine 24 (September): 11064–69. doi:10.1111/jcmm.15755.